Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
06:33am, Thursday, 02'nd May 2024
Moderna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine maker looks to launch its second product in the U.S. later this year.
Stock Market Crash Warning: Don't Get Caught Holding These 3 Cathie Wood Stocks
06:00am, Thursday, 02'nd May 2024
For a time, Cathie Wood was the hottest investor on Wall Street. Ark Invest was bringing in billions of dollars in new assets under management.
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street's Radar
02:38pm, Wednesday, 01'st May 2024
Biotech stocks are full of intriguing innovators who could help pave the way for greater gains over the years ahead. Undoubtedly, it's virtually impossible to tell exactly which pills, shots and treat
Why Earnings Season Could Be Great for Moderna (MRNA)
12:11pm, Wednesday, 01'st May 2024
Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
03:20pm, Tuesday, 30'th Apr 2024
Biotech stocks offer the opportunity to invest in life-saving treatments and drugs. So not only can you make massive gains but you are also investing in the advancement of modern medicine.
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
12:21pm, Tuesday, 30'th Apr 2024
Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Tuesday, 30'th Apr 2024
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
12:36pm, Monday, 29'th Apr 2024
Investors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
The most jam-packed earnings week for the quarter lies ahead, led by these two market bellwethers
10:01am, Sunday, 28'th Apr 2024
This week, 175 companies in the S&P 500 index report quarterly results, making it the busiest for the U.S. earnings reporting season overall. But amid the stampede, much of Wall Street's attention wil
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
07:06pm, Friday, 26'th Apr 2024
Moderna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous trading session.
AI is evolving and investors need to change with it. Here's what to expect.
07:10am, Friday, 26'th Apr 2024
The market for artificial intelligence is undergoing a profound transformation, reshaping industries and investment strategies alike. Rapid advancements and integration across sectors and understandin
Should You Buy Moderna Before May 12?
04:50am, Friday, 26'th Apr 2024
Investors have worried about Moderna's growth prospects as demand for its coronavirus vaccine declines. Moderna may have a new billion-dollar product right around the corner.
Moderna cancer vaccine offers long-term hope in melanoma
04:06am, Friday, 26'th Apr 2024
Covid vaccine maker Moderna Inc and partner Merck Sharp and Dohme (MSD) have initiated a phase III trial in the UK for the world's first "personalised" mRNA vaccine, mRNA-4157 (V940), targeting mel
Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy
01:38pm, Tuesday, 23'rd Apr 2024
While artificial intelligence may be useful for a variety of purposes – including asking silly questions we're afraid to pose in real life – the ultimate end game for digital intelligence could be
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
07:21am, Tuesday, 23'rd Apr 2024
Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday.
